On ECHEMI

Hangzhou Heta Pharm & Chem Co., Ltd

Hangzhou,Zhejiang,China
Favorite Supplier
 1397 people visit

Company Profile

Founded in 2001,Hangzhou HETA Pharm & Chem Co., Ltd. is a pharmaceutical company specializing in the research, development, production and custom synthesis of APIs, preparations, intermediates and impurities. Now, we provide a wide range of products, including anti-tumor, anti-viral and hypoglycemic drugs such as Fulvestrant, anastrozole, letrozole, TFA, TDA, oseltamivir phosphate, sitagliptin phosphate and acyclovir, etc. Located in Hangzhou Zijingang Technology City (formerly West Lake Technology Park), we enjoy convenient transportation and a strong academic atmosphere for we are very close to Zhejiang University. There are nearly 80 employees, more than 90% of them have a bachelor degree or above, and more than 50% have master's degree or above. Moreover, we have good relationships of cooperation with China Pharmaceutical University, Zhejiang University, China Medical University, SIOC, SIMM, CSIPI, and other universities and research institutions. HETA has established an API factory in Linhai National API Base in Taizhou city, and this factory obtained the GMP certificate of China and FDA certification. Up to now, this factory has successfully got the production approval numbers for three APIs. HETA has made remarkable progress in recent years, and all achievements are coming from the innovation and differentiation of enterprise. We will do our utmost to achieve a new round of technological breakthroughs to serve customers; we also strive to be a leading company by producing excellent quality, and work with customers for creating a win-win situation!

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone

1,5-Pentanedione,1-(4-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-;2-Oxazolidinone,3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-,(S)-;2-Oxazolidinone,3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-,(4S)-;1-(4-Fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-1,5-pentanedione;(4S)-4-Phenyl-3-[5-(4-fluorophenyl)-5-oxopentanoyl]-1,3-oxazolidin-2-one;(S)-3-[5-(4-Fluorophenyl)-1,5-dioxopentyl]-4-phenyloxazolidin-2-one;(S)-3-[4-(4-Fluorobenzoyl)-1-oxobutyl]-4-phenyloxazolidin-2-one;(S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione;1-(4-Fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]pentane-1,5-dione
189028-93-1 Inquiry

(R)-(+)-1-(1-Naphthyl)ethylamine

1-Naphthalenemethanamine,α-methyl-,(αR)-;1-Naphthalenemethylamine,α-methyl-,(R)-(+)-;1-Naphthalenemethanamine,α-methyl-,(R)-;(αR)-α-Methyl-1-naphthalenemethanamine;(+)-α-(1-Naphthyl)ethylamine;d-1-(1-Naphthyl)ethylamine;(R)-(+)-α-(1-Naphthyl)ethylamine;(+)-1-(1-Naphthyl)ethylamine;(+)-1-(α-Naphthyl)ethylamine;(R)-α-(1-Naphthyl)ethylamine;(R)-1-(1-Naphthyl)ethylamine;(R)-1-(α-Naphthyl)ethylamine;(R)-(+)-1-(1-Naphthyl)ethylamine;(R)-(+)-1-(α-Naphthyl)ethylamine;(R)-1-(1-Naphthyl)ethanamine;(R)-1-Naphthylethylamine;(R)-α-Methyl-1-naphthalenemethanamine;(R)-(+)-1-(1-Naphthyl)ethylamine;[(R)-1-(Naphthalen-1-yl)ethyl]amine;(1R)-1-(1-Naphthyl)ethanamine;(R)-1-(Naphthalen-1-yl)ethanamine;(+)-[(R)-1-(Naphthalen-1-yl)ethyl]amine;(R)-1-(1-Naphthalenyl)ethylamine;(R)-1-(Naphthalen-1-yl)ethan-1-amine;(1R)-1-(Naphthalen-1-yl)ethan-1-amine;(1R)-1-Naphthalen-1-ylethanamine
3886-70-2 Inquiry

(R)-(+)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol

2-Pyrrolidinemethanol,α,α-diphenyl-,(2R)-;2-Pyrrolidinemethanol,α,α-diphenyl-,(R)-;(2R)-α,α-Diphenyl-2-pyrrolidinemethanol;α,α-Diphenyl-D-prolinol;(R)-α,α-Diphenylprolinol;(R)-α,α-Diphenyl-2-pyrrolidinemethanol;(+)-α,α-Diphenyl-2-pyrrolidinemethanol;(R)-2-(diphenylhydroxymethylpyrrolidine);(+)-2-(Diphenylhydroxymethyl)pyrrolidine;(R)-(+)-α,α-Diphenyl-2-pyrrolidinemethanol;(R)-Diphenyl-2-pyrrolidinylmethanol;(R)-(+)-α,α-Diphenyl-2-pyrrolidinemethanol;(R)-Diphenyl(pyrrolidin-2-yl)methanol;(R)-(+)-2-(Diphenylhydroxymethyl)pyrrolidine;1609983-10-9
22348-32-9 Inquiry

(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid

(r)-(-)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid;(r)-(-)-3-carbamoymethyl-5-methylhexanoic acid;INTERMEDIATE OF PREGABALIN;(3R)-3-(2-AMino-2-oxoethyl)-5-Methylhexanoic Acid;(R)-3-(2-AMINO-2-OXOETHYL)-5-METHYLHEXANOIC ACID:99+%;3-CarbaMoyl Mehyl-5-Methyl Hexanoic Acid;Pregabalin IMpurity III;Hexanoic acid,3-(2-aMino-2-oxoethyl)-5-Methyl-,(3R)-
181289-33-8 Inquiry

(R)-2-Flurbiprofen

[1,1′-Biphenyl]-4-acetic acid,2-fluoro-α-methyl-,(αR)-;[1,1′-Biphenyl]-4-acetic acid,2-fluoro-α-methyl-,(R)-;(αR)-2-Fluoro-α-methyl[1,1′-biphenyl]-4-acetic acid;(-)-Flurbiprofen;l-Flurbiprofen;R-(-)-Flurbiprofen;(-)-(R)-Flurbiprofen;(R)-Flurbiprofen;E 7869;MPC 7869;Tarenflurbil;Flurizan;(R)-(-)-2-(2-Fluorobiphenyl-4-yl)propionic acid;(R)-Flurbiprofen;(2R)-2-(3-Fluoro-4-phenylphenyl)propanoic acid
51543-40-9 Inquiry

(S)-(?)-α,α-Diphenyl-2-pyrrolidinemethanol

2-Pyrrolidinemethanol,α,α-diphenyl-,(2S)-;2-Pyrrolidinemethanol,α,α-diphenyl-,(S)-;(2S)-α,α-Diphenyl-2-pyrrolidinemethanol;(S)-(-)-2-(Diphenylhydroxymethyl)pyrrolidine;(S)-α,α-Diphenyl-2-pyrrolidinemethanol;(-)-2-(Diphenylhydroxymethyl)pyrrolidine;(S)-α,α-Diphenylprolinol;(-)-α,α-Diphenylprolinol;(S)-(-)-α,α-Diphenyl-2-pyrrolidinemethanol;(S)-2-(Diphenylhydroxymethyl)pyrrolidine;(-)-α,α-Diphenyl-2-pyrrolidinemethanol;(S)-α,α-Diphenylpyrrolidin-2-ylmethanol;(S)-2-(Hydroxydiphenylmethyl)pyrrolidine;(S)-Diphenyl(pyrrolidin-2-yl)methanol;α,α-Diphenyl-L-prolinol;(S)-α,α-Diphenylpyrrolidinemethanol;(S)-(-)-α,α-Diphenylprolinol;1609983-09-6
112068-01-6 Inquiry

(S)-3-Aminoquinuclidine dihydrochloride

1-Azabicyclo[2.2.2]octan-3-amine,hydrochloride (1:2),(3S)-;1-Azabicyclo[2.2.2]octan-3-amine,dihydrochloride,(S)-;1-Azabicyclo[2.2.2]octan-3-amine,dihydrochloride,(3S)-;3(S)-Aminoquinuclidine dihydrochloride;(S)-3-Aminoquinuclidine dihydrochloride;(S)-(-)-3-Aminoquinuclidine dihydrochloride;(3S)-3-Aminoquinuclidine dihydrochloride;(3S)-1-Azabicyclo[2.2.2]octan-3-amine dihydrochloride;(S)-Quinuclidin-3-amine dihydrochloride
119904-90-4 Inquiry

1,2,3-Triacetyl-5-deoxy-D-ribose

β-D-Ribofuranose,5-deoxy-,1,2,3-triacetate;β-D-Ribofuranose,5-deoxy-,triacetate;1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose
62211-93-2 Inquiry

1-beta-D-Arabinofuranosylcytosine hydrochloride

2(1H)-Pyrimidinone,4-amino-1-β-D-arabinofuranosyl-,hydrochloride (1:1);Cytosine,1-β-D-arabinofuranosyl-,monohydrochloride;2(1H)-Pyrimidinone,4-amino-1-β-D-arabinofuranosyl-,monohydrochloride;U 19920A;1-β-D-Arabinofuranosylcytosine hydrochloride;Cytarabine hydrochloride;Cytosine arabinoside hydrochloride;Aracytidine hydrochloride;1-β-D-Arabinofuranosylcytosine monohydrochloride;Arabinofuranosylcytosine hydrochloride;Arabinosylcytosine hydrochloride;Spongocytidine-hydrochloride
69-74-9 Inquiry

17-(3-pyridyl)-5,16-androstadien-3beta-acetate

Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-,acetate (ester),(3β)-;CB 7630;Abiraterone acetate;Zytiga;(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate;1643848-36-5
154229-18-2 Inquiry

2-(3-Aminopropylamino)ethylsulfanylphosphonic acid trihydrate

112901-68-5 Inquiry

2-(Difluoromethyl)-DL-ornithine

EFLORNITHINE;2-(Difluoromethyl)-DL-ornithine;alpha-Difluoromethylornithine hydrochloride;2,5-bis(azanyl)-2-(difluoromethyl)pentanoic acid hydrochloride;2,5-diamino-2-(difluoromethyl)pentanoic acid hydrochloride;2,5-diamino-2-(difluoromethyl)valeric acid hydrochloride;Eflornithine API
70050-56-5 Inquiry

3,5-Bis(2-cyanoprop-2-yl)benzyl bromide

1,3-Benzenediacetonitrile,5-(bromomethyl)-α1,α1,α3,α3-tetramethyl-;1,3-Benzenediacetonitrile,5-(bromomethyl)-α,α,α′,α′-tetramethyl-;5-(Bromomethyl)-α1,α1,α3,α3-tetramethyl-1,3-benzenediacetonitrile;3,5-Bis(2-cyanoprop-2-yl)benzyl bromide;3,5-Bis(1-cyano-1-methylethyl)benzyl bromide;2,2′-(5-(Bromomethyl)-1,3-phenylene)bis(2-methylpropanenitrile);2-[3-(Bromomethyl)-5-(2-cyanopropan-2-yl)phenyl]-2-methylpropanenitrile
120511-84-4 Inquiry

3,5-Bis(2-cyanoprop-2-yl)toluene

1,3-Benzenediacetonitrile,α1,α1,α3,α3,5-pentamethyl-;1,3-Benzenediacetonitrile,α,α,α′,α′,5-pentamethyl-;α1,α1,α3,α3,5-Pentamethyl-1,3-benzenediacetonitrile;2,2′-(5-Methyl-1,3-phenylene)di(2-methylpropionitrile);3,5-Bis(2-cyanoprop-2-yl)toluene;3,5-Bis(2-cyano-2-methylethyl)toluene;2-[3-(Cyanodimethylmethyl)-5-methylphenyl]-2-methylpropionitrile;2,2′-(5-Methyl-1,3-phenylene)bis(2-methylpropanenitrile);2,2′-(5-methylbenzene-1,3-diyl)bis(2-methylpropanenitrile);2-[3-(2-Cyanopropan-2-yl)-5-methylphenyl]-2-methylpropanenitrile
120511-72-0 Inquiry

3-(Aminomethyl)-5-methylhexanoic acid

Pregabalin Racemate;Racemic Pregabalin (3-(Aminomethyl)-5-Methylhexanoic Acid);rac-Pregabalin-d10;RAC PREGABALIN;rac-CI-1008;rac-PD-144723;(RS)-3-AMINOMETHYL-5-METHYLHEXANOIC ACID;3-(Aminomethyl)-5-methylhexanoic acid
128013-69-4 Inquiry

3-(N-Methylpentylamino)propionic acid hydrochloride

β-Alanine,N-methyl-N-pentyl-,hydrochloride (1:1);β-Alanine,N-methyl-N-pentyl-,hydrochloride;Ibanic acid hydrochloride;N-Methyl-N-pentyl-β-alanine hydrochloride
625120-81-2 Inquiry

3-(s)-(+)-(1-cyano-1,1-diphenylmethyl)-1-tosylpyrrolidine

3-Pyrrolidineacetonitrile,1-[(4-methylphenyl)sulfonyl]-α,α-diphenyl-,(3S)-;3-Pyrrolidineacetonitrile,1-[(4-methylphenyl)sulfonyl]-α,α-diphenyl-,(S)-;(3S)-1-[(4-Methylphenyl)sulfonyl]-α,α-diphenyl-3-pyrrolidineacetonitrile;(S)-2,2-Diphenyl-2-(1-tosyl-3-pyrrolidinyl)acetonitrile;2,2-Diphenyl-2-((3S)-1-tosyl-3-pyrrolidinyl)acetonitrile;(S)-3-(1-Cyano-1,1-diphenylmethyl)-1-tosylpyrrolidine;2-[(3S)-1-(4-Methylphenyl)sulfonylpyrrolidin-3-yl]-2,2-diphenylacetonitrile
133099-09-9 Inquiry

3-Carbamoymethyl-5-methylhexanoic acid

Hexanoic acid,3-(2-amino-2-oxoethyl)-5-methyl-;3-(2-Amino-2-oxoethyl)-5-methylhexanoic acid;3-(Carbamoylmethyl)-5-methylhexanoic acid
181289-15-6 Inquiry

3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone

3-[(2R,5S)-5-(4-FLUOROPHENYL)-2-[(S)-[(4-FLUOROPHENYL(AMINO)]] [4-[TRIMETHYLSILYL]-OXY]PHENYL]METHYL]-1-OXO-5-[(TRIMETHYLSILY)-OXY]PENTYL]-4-PHENYL-(4S)-2-OXAZOLIDINONE;2-OXAZOLIDINONE, 3-[(2R,5S)-5-(4-FLUOROPHENYL)-2-[(S)-[(4-FLUOROPHENYL)AMINO][4-[(TRIMETHYLSILYL)OXY]PHENYL]METHYL]-1-OXO-5-[(TRIMETHYLSILYL)OXY]PENTYL]-4-PHENYL-, (4S)-;3-[(2r,5s)-5-(4-Fluorophenyl)-2-[(S)-[(4-Fluorophenyl( Amino)]][4-[Trimethylsilyl]-Oxy]Phenyl]Methyl]-1-Oxo-5-[(Trimethylsilyl)-Oxy]Pentyl]-4-Phenyl-(4s)-2-Oxazolidinone;3-[(2R,5S)-5-(4-fluorophenyl)-2-{(S)-[4-fluorophenyl]Amino}[4-(trimethylsily)-oxy]pentyl]methyl-1-2oxo-5-(trimethylsilyl)-oxo]penyl]-4-phenyl-(4S)-2-oxazolidinone;3-[(2R,5S)-5-(4-FLUOROPHENYL)-2-[(S)-[(4-FLUOROPHENYL( AMINO)]] [4-[TRIMETHYLSILYL]-OXY]PHENYL]METHYL]-1-OXO-5-[(TRIMETHYLSILY) -OXY]PENTYL]-4-PHENYL-(4S)- 2-OXAZOLIDINONE(INTERMEDIATE OF EZETIMIBE);INTERMEDIATE OF EZETIMIBE
272778-12-8 Inquiry

4,4'-(Chloromethylene)-bis-benzonitrile

4,4'-(chloromethylene)-bis-benzonitrile;4-[A-(4-CYANOPHENYL)-CHLOROMETHYL]BENZONITRILE;4-ALPHA-(4-CYANOPHENYL)-CHLOROMETHYL-BENZONITRILE;4-[ α - (4-CYANOPHENYL)-CHLOROMETHYL]BENZONITRILE(MEDIATE FOR LETROZOLE);4-[a-(4-Cyanophenyl)-chloromethyl]-benzonitrile(ForLetrozole);4-α-(4-Cyanophenyl)chloromethylbenzonitrile;4-[α-(4-Cyanophenyl)-chloromethyl]-benzonitrile ( For Letrozole );4-[ A - (4-CYANOPHENYL)-CHLOROMETHYL]BENZONITRILE(MEDIATE FOR LETROZOLE)
112809-57-1 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

United States

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.